Patient experience and satisfaction with Onabotulinumtoxin A for refractory overactive bladder

Area of Science:

• Urology
• Patient Experience Research
• Pharmacology

Background:

• Refractory idiopathic detrusor overactivity (IDO) significantly impacts quality of life.
• Botulinum toxin A (BTX-A) injections are an established treatment for IDO.
• Evaluating patient experience is crucial for service improvement.

Purpose of the Study:

• To assess patient experience with a dedicated BTX-A service.
• To measure patient satisfaction with BTX-A treatment for IDO.
• To utilize patient-reported experience measures (PREMs) for service evaluation.

Main Methods:

• Telephone interviews with 72 patients treated for IDO.
• Utilized the validated Client Satisfaction Questionnaire (CSQ-8) PREM.
• Administered a custom questionnaire assessing treatment outcome satisfaction.

Main Results:

• High overall patient satisfaction with the BTX-A service (mean CSQ-8 score 38.3/45).
• Patients continuing BTX-A reported significantly higher satisfaction than those who discontinued (P < 0.01).
• High patient satisfaction with treatment results (mean VAS 8.6/10).

Conclusions:

• The dedicated BTX-A service provides a high level of patient satisfaction.
• BTX-A treatment can lead to a positive patient experience for IDO.
• PREMs are valuable tools for assessing healthcare service quality and patient satisfaction.